Italian guidelines for the management and treatment of neonatal cholestasis

Costantino Romagnoli, Carlo Dani, Simone Pratesi, Francesco Raimondi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

22 Citazioni (Scopus)

Abstract

Hyperbilirubinemia is a frequent condition affecting newborns during the first two weeks of life and when it lasts more than 14 days it is defined as prolonged jaundice. This condition requires differential diagnosis between the usually benign unconjugated hyperbilirubinemia and the pathological conjugated hyperbilirubinemia, that is mainly due to neonatal cholestasis. It is important that the diagnosis of neonatal cholestasis be well-timed to optimize its management, prevent worsening of the patient's outcome, and to avoid premature, painful, expensive, and useless tests. Unfortunately, this does not always occur and, therefore, the Task Force on Hyperbilirubinemia of the Italian Society of Neonatology presents these shared Italian guidelines for the management and treatment of neonatal cholestasis whose overall aim is to provide a useful tool for its assessment for neonatologists and family pediatricians.
Lingua originaleEnglish
pagine (da-a)69-69
Numero di pagine1
RivistaTHE ITALIAN JOURNAL OF PEDIATRICS
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • neonatal cholestasis

Fingerprint Entra nei temi di ricerca di 'Italian guidelines for the management and treatment of neonatal cholestasis'. Insieme formano una fingerprint unica.

Cita questo